DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cipla Share Price Live Updates: Cipla's Stock Price Overview

Economic Times 3 hrs ago·11 Aug 2026, 2:50 am

Cipla's stock is currently in focus as the company updates investors on its latest performance and strategic outlook. This live coverage tracks the share price movements and key developments affecting the pharmaceutical giant.

For investors, this update is significant as it offers a real-time look at market sentiment and the company's operational health. Monitoring these live updates helps retail investors gauge the immediate impact of news on the stock's valuation and make informed decisions based on the latest information.

Investors should watch for details on the company's earnings guidance, product pipeline progress, and any management commentary regarding market trends. Keeping an eye on these factors will provide clarity on the stock's future direction.